| Record Information |
| Version |
3.5 |
| Creation Date |
2006-08-13 04:47:12 -0600 |
| Update Date |
2013-02-08 17:13:00 -0700 |
| HMDB ID |
HMDB04095 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
5-Methoxytryptamine |
| Description |
Serotonin derivative proposed as potentiator for hypnotics and sedatives. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 2-(5-Methoxy-1H-indol-3-yl)ethanamine
- 2-(5-Methoxyindol-3-yl)ethylamine
- 3-(2-Aminoethyl)-5-methoxyindole
- 5-Mot
- 5MOT
- Lopac-M-6628
- Meksamin
- Methoxytryptamine
- Mexamine
- Mexamine base
|
| Chemical Formula |
C11H14N2O |
| Average Molecular Weight |
190.2417 |
| Monoisotopic Molecular Weight |
190.11061308 |
| IUPAC Name |
2-(5-methoxy-1H-indol-3-yl)ethan-1-amine |
| Traditional IUPAC Name |
5-methoxytryptamine |
| CAS Registry Number |
608-07-1 |
| SMILES |
COC1=CC2=C(NC=C2CCN)C=C1 |
| InChI Identifier |
InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 |
| InChI Key |
JTEJPPKMYBDEMY-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aromatic Heteropolycyclic Compounds |
| Class |
Indoles |
| Sub Class |
Tryptamines and Derivatives |
| Other Descriptors |
- Indoles
- Tryptamines and Derivatives
- a small molecule(Cyc)
- tryptamines(ChEBI)
|
| Substituents |
- Alkyl Aryl Ether
- Anisole
- Primary Aliphatic Amine (Alkylamine)
- Pyrrole
|
| Direct Parent |
Serotonins |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
Not Available |
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
121.5 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-MS |
| MS/MS Spectrum GC-MS |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
Not Available
|
| Biofluid Locations |
|
| Tissue Location |
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Urine |
Detected and Quantified |
|
0.0016 (0.0-0.0032) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB023311 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
1767  |
| KEGG Compound ID |
C05659  |
| BioCyc ID |
N-ACETYL-5-METHOXY-TRYPTAMINE  |
| BiGG ID |
Not Available |
| Wikipedia Link |
5-Methoxytryptamine  |
| NuGOwiki Link |
HMDB04095  |
| Metagene Link |
HMDB04095  |
| METLIN ID |
7015  |
| PubChem Compound |
1833  |
| PDB ID |
Not Available |
| ChEBI ID |
2089  |
| References |
| Synthesis Reference |
Szmuszkovicz, J.; Anthony, W. C.; Heinzelman, R. V. N-Acetyl-5-methoxytryptamine. Journal of Organic Chemistry (1960), 25 857-9. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Rom-Bugolavskaia ES, Shcherbakova VS, Komarova IV: [The effect of melatonin and mexamine on the human thyroid under in-vitro conditions] Eksp Klin Farmakol. 1997 Jul-Aug;60(4):46-9.
Pubmed: 9376758
- Kirchheiner J, Henckel HB, Franke L, Meineke I, Tzvetkov M, Uebelhack R, Roots I, Brockmoller J: Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets. Pharmacogenet Genomics. 2005 Aug;15(8):579-87.
Pubmed: 16007002
- Romsing S, Bokman F, Bergqvist Y: Determination of melatonin in saliva using automated solid-phase extraction, high-performance liquid chromatography and fluorescence detection. Scand J Clin Lab Invest. 2006;66(3):181-90.
Pubmed: 16714247
- Geffard M, Dulluc J, Rock AM: Antisera against the indolealkylamines: tryptophan, 5-hydroxytryptophan, 5-hydroxytryptamine, 5-methoxytryptophan, and 5-methoxytryptamine tested by an enzyme-linked immunosorbent assay method. J Neurochem. 1985 Apr;44(4):1221-8.
Pubmed: 3919158
|